Pages that link to "Q37361629"
Jump to navigation
Jump to search
The following pages link to A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance (Q37361629):
Displaying 50 items.
- Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules (Q27022700) (← links)
- Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone (Q28188786) (← links)
- Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors (Q28277019) (← links)
- Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression (Q28570423) (← links)
- Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling (Q28579441) (← links)
- Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene (Q33291238) (← links)
- Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training (Q34031701) (← links)
- MSI-1436 reduces acute food intake without affecting dopamine transporter activity (Q34155566) (← links)
- PTP1B: from the sidelines to the front lines! (Q34209253) (← links)
- Association of the human adiponectin gene and insulin resistance (Q34543913) (← links)
- A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants (Q34568722) (← links)
- Association ofParaoxonase 1 (PON1)polymorphisms with osteoporotic fracture risk in postmenopausal Korean women (Q34616983) (← links)
- Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities (Q34655620) (← links)
- Identification of a shared F8 mutation in the Korean patients with acquired hemophilia A (Q34729308) (← links)
- Tea contains potent inhibitors of tyrosine phosphatase PTP1B. (Q34762011) (← links)
- Protein tyrosine phosphatase 1B inhibitors for diabetes (Q34810384) (← links)
- Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery. (Q34967191) (← links)
- Deficiency of PTP1B in POMC neurons leads to alterations in energy balance and homeostatic response to cold exposure (Q35055467) (← links)
- PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity (Q35056063) (← links)
- Genetic evaluation for coronary artery disease (Q35179025) (← links)
- PTP1B deficiency exacerbates inflammation and accelerates leukocyte trafficking in vivo. (Q35659215) (← links)
- Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans (Q35976750) (← links)
- The Genetics of PTPN1 and Obesity: Insights from Mouse Models of Tissue-Specific PTP1B Deficiency (Q36090563) (← links)
- Type 2 diabetes: principles of pathogenesis and therapy (Q36095054) (← links)
- Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities (Q36907969) (← links)
- Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle (Q36951684) (← links)
- Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22 (Q37088189) (← links)
- Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans (Q37379556) (← links)
- Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity (Q37412376) (← links)
- Epidermal barrier dysfunction in atopic dermatitis. (Q37507508) (← links)
- Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population (Q37509782) (← links)
- Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. (Q37634961) (← links)
- Overview of pharmacogenetics (Q37938905) (← links)
- PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis (Q37992232) (← links)
- Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites. (Q38194186) (← links)
- Protein Tyrosine Phosphatase 1B Inhibitors from the Roots of Cudrania tricuspidata (Q38993890) (← links)
- Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance (Q40177903) (← links)
- Antiobesity and Antidiabetes Effects of a Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential. (Q41952680) (← links)
- Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism (Q42146973) (← links)
- A novel mechanism for variable phenotypic expressivity in Mendelian diseases uncovered by an AU-rich element (ARE)-creating mutation (Q42339325) (← links)
- Elevation of PTPN1 promoter methylation is a significant risk factor of type 2 diabetes in the Chinese population (Q42376412) (← links)
- The allelic variant of LAR gene promoter -127 bp T-->A is associated with reduced risk of obesity and other features related to insulin resistance (Q42461854) (← links)
- Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B. (Q42716649) (← links)
- PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol (Q43153459) (← links)
- Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case-control study in Chinese population (Q43184327) (← links)
- Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice (Q43193940) (← links)
- Polymorphism in 3′‐untranslated region of toll‐like receptor 4 gene is associated with protection from hepatitis B virus recurrence after liver transplantation (Q43959782) (← links)
- Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity (Q44221551) (← links)
- Genetic variations in CCK₂ receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure (Q44412252) (← links)
- Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms (Q44629006) (← links)